Recently, the whole chain of novel coronavirus nucleic acid detection products developed by TargetingOne has been granted CE market access in the European Union, providing two technical solutions for global anti-epidemic with excellent fluorescent quantitative PCR (qPCR) and digital PCR, which have outstanding advantages such as high sensitivity, accurate results and easy operation.
Novel Coronavirus(2019-nCov) detection products received the EU CE market access qualification
Full Chain Solution for Novel Coronavirus Testing
Home test, easy to use
Higher biosafety, sampling and virus inactivation synchronization
Wide range of specifications and scenes to meet different sampling needs of customers
Effectively maintain virus activity, facilitate downstream immunization research
Effectively improve the detection rate of positive viruses and avoid false negatives